
3 & 2 Pharma LLC Profile last edited on: 1/26/2024
CAGE: 8FRN8
UEI: CA73TAZPAVM8
Business Identifier: NO Business Identifier is currently available for this company. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 28
County: Los Angeles
Congr. District: 28
County: Los Angeles
Public Profile
SBA indicated as dba 3 & 2 Pharma LLC, the firm is also listed elsewhere as 3+2 Pharma, LLC with an apparantly non-operational website designated www.wolfenet.com.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2022 | 1 | NIH | $334,008 | |
Project Title: Novel Orally Available CBP/Beta-Catenin Antagonists to Treat Idiopathic Pulmonary Fibrosis |
Key People / Management
Omar Haffar -- Chief Executive Officer
David Horne
David Horne
Company News
There are no news available.